Clinical trial
PhaRmacodynamic Effect of Antiplatelet Agents in Elderly Patients: Standard Clopidogrel Versus prasugrEl Low Dose Therapy.
NCT01778842 is registered in ClinicalTrials.gov with Gennaro Sardella as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PhaRmacodynamic Effect of Antiplatelet Agents in Elderly Patients: Standard Clopidogrel Versus prasugrEl Low Dose Therapy.
- Lead sponsor
- Gennaro Sardella
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2013
- Completion date
- July 31, 2013
- Enrollment
- 68 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.